论文部分内容阅读
华北制药集团有限责任公司是“一五”期间我国投资的最大国有制药企业。目前是国内最大的抗生素原料药生产营销基地和最大的粉针制剂生产企业,是全国六家技术创新试点企业之一。40多年来,华药秉承“一切为了人类健康”的经营宗旨,务实创新,逐步壮大,主要经济效益指标始终处于同行业前列。华药现已拥有总资产155亿元,职工18000余人,产品结构已经由抗生素为主发展为抗生素、半合成抗生素、维生素、基因工程药物、保健品和生物农、兽药等产品共350多个品种,成为拥有30多家子公司、多元投资主体的集科、工、贸、金
North China Pharmaceutical Group Co., Ltd. is the largest state-owned pharmaceutical enterprise invested by China in the “First Five-Year Plan” period. At present, it is the largest production and marketing base of antibiotic APIs and the largest manufacturer of powder preparation in the country and is one of six pilot enterprises for technological innovation in China. For more than 40 years, Huabao adheres to the business principle of “all for human health”, pragmatic innovation, and gradually expand, the main indicators of economic efficiency has always been in the forefront of the industry. Huabao now has total assets of 15.5 billion yuan, more than 18000 employees, the product structure has been the development of antibiotics antibiotics, semi-synthetic antibiotics, vitamins, genetic engineering drugs, health products and biological pesticides, veterinary drugs and other products a total of more than 350 varieties It has become a branch, worker, trade and gold company with more than 30 subsidiaries and diversified investors